$0.401100
-0.04-8.86%
Last update: 11:42 AM
15 minutes delayed
Comments
Loading...
Aptevo Therapeutics
APVONASDAQ
Aptevo Therapeutics (NASDAQ:APVO) Stock, Earnings Estimates, EPS, And Revenue
Aptevo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-6.550
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Aptevo Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| APVO | Aptevo Therapeutics | -$54.12 | -$6.55 | — | — | $0.00 | — | — | — | 08/08/2024 | Get Alert |
| APVO | Aptevo Therapeutics | $11.45 | -$12.84 | -$9.95 | 22.51% | $0.00 | — | $0.00 | — | 05/08/2024 | Get Alert |
| APVO | Aptevo Therapeutics | -$63.36 | -$18.04 | -$1.76 | 90.24% | $0.00 | — | $0.00 | — | 03/05/2024 | Get Alert |
| APVO | Aptevo Therapeutics | -$66.00 | -$33.00 | -$22.00 | 33.33% | $0.00 | — | $0.00 | — | 11/14/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$80.08 | -$49.28 | -$54.12 | -9.82% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$68.20 | -$51.92 | -$43.12 | 16.95% | $3.11M | — | $0.00 | — | 05/11/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$58.52 | -$67.32 | -$63.36 | 5.88% | $3.67M | — | $0.00 | — | 03/30/2023 | Get Alert |
| APVO | Aptevo Therapeutics | -$62.92 | -$72.16 | -$66.00 | 8.54% | $3.10M | — | $0.00 | — | 11/10/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$78.32 | -$58.52 | -$80.08 | -36.84% | $3.11M | $3.42M | $0.00 | -100.00% | 08/11/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$72.16 | -$50.60 | -$68.20 | -34.78% | $2.42M | $3.75M | $3.11M | -16.96% | 05/12/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$77.88 | -$56.76 | -$58.52 | -3.10% | $2.37M | $3.40M | $3.67M | 7.79% | 03/24/2022 | Get Alert |
| APVO | Aptevo Therapeutics | -$94.60 | -$64.68 | -$62.92 | 2.72% | $1.46M | $3.65M | $3.10M | -15.18% | 11/12/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$92.40 | -$80.96 | -$78.32 | 3.26% | $473.00K | $900.00K | $3.11M | 245.56% | 08/12/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$106.04 | $74.36 | -$76.56 | -202.96% | $0.00 | $2.42M | $2.42M | 0.04% | 05/11/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$117.04 | -$58.08 | -$77.88 | -34.09% | $9.03M | $2.16M | $2.37M | 9.86% | 03/31/2021 | Get Alert |
| APVO | Aptevo Therapeutics | -$141.68 | — | -$94.60 | — | $9.01M | — | $1.46M | — | 11/10/2020 | Get Alert |
| APVO | Aptevo Therapeutics | -$184.80 | — | -$92.40 | — | $7.36M | — | $473.00K | — | 08/14/2020 | Get Alert |
| APVO | Aptevo Therapeutics | -$271.04 | — | -$106.04 | — | $7.02M | — | $0.00 | — | 05/13/2020 | Get Alert |
| APVO | Aptevo Therapeutics | -$381.92 | — | -$117.04 | — | $6.35M | — | $9.03M | — | 03/25/2020 | Get Alert |
| APVO | Aptevo Therapeutics | -$338.80 | — | -$141.68 | — | $5.80M | — | $9.01M | — | 11/07/2019 | Get Alert |
| APVO | Aptevo Therapeutics | -$357.28 | — | -$184.80 | — | $6.83M | — | $7.36M | — | 08/09/2019 | Get Alert |
Aptevo Therapeutics (APVO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $-9.95 | $-12.84 | 22.5 % |
| Dec 2023 | 2024-03-05 | $-1.76 | $-18.04 | 90.2 % |
| Sep 2023 | 2023-11-14 | $-22.00 | $-33.00 | 33.3 % |
| Jun 2023 | 2023-08-10 | $-54.12 | $-49.28 | -9.82 % |
Aptevo Therapeutics (APVO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2022 | 2022-08-11 | $0 | $3.42M | -100.0 % |
| Mar 2022 | 2022-05-12 | $3.11M | $3.75M | -17.0 % |
| Dec 2021 | 2022-03-24 | $3.67M | $3.40M | 7.79 % |
| Sep 2021 | 2021-11-12 | $3.10M | $3.65M | -15.2 % |
FAQ
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
Aptevo Therapeutics (APVO) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for Aptevo Therapeutics (NASDAQ:APVO)?
The Actual EPS was $-9.95, which beat the estimate of $-12.84.
What were Aptevo Therapeutics’s (NASDAQ:APVO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.